Category: Press Releases

FDA Approves Medicines360’s LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Eight Years

Medicines360 Calls on U.S. Congress to Pass Affordability is Access Act Without Delay 

In the Wake of Supreme Court Decision, Medicines360 Stands With Women

Medicines360 Applauds HELP Committee for Including Critical Amendments on Nonprofit Pharma in Legislation Headed to Senate Floor  

Medicines360 Applauds Sens. Rosen and Romney for Introducing Critical Legislation to Explore Benefits of Nonprofit Pharmaceutical Model

Medicines360 Appoints Elizabeth Garner, M.D., M.P.H. to Board of Directors